About BioServe Biotechnologies
BioServe Biotechnologies is a Healthcare company based in Hyderabad (India) founded in 2002, and was acquired by ReproCELL in April 2018. DNA synthesis, sequencing, extraction, and biomarker discovery services are provided. The company has 28 employees. Its Indian entity Bioserve Biotechnologies (India) Private Limited reported revenue of ₹4.20 Cr. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Genomics.
Company details
BioServe Biotechnologies was founded in 2002 in Hyderabad, India, within the biotechnology sector. DNA synthesis, sequencing, extraction, and biomarker discovery services are offered to support research and diagnostics. Therapeutics targeting Rett syndrome, Parkinsons disease, glioblastoma, CDKL5 deficiency disorder, and related conditions are developed. Additional services include food pathogen testing and detection of genetically modified organisms in finished products. Molecular biology kits for research purposes are manufactured and supplied.
- Headquarters Hyderabad, India
- Employees 28
- Stage Acquired
- SectorsHealthcare
- Website bioserveindia.com
- Social LinkedIn
- Acquired by ReproCELL (Apr 2018)
- Legal Name Bioserve Biotechnologies (India) Private Limited
- Date of Incorporation 21 Feb, 1994
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹4.20 Cr
FY 2025 · +32% YoY
- Net Loss-₹2.24 Cr
FY 2025 · -53% margin
- EBITDA-₹79.7 Lakh
FY 2025 · -19% margin
- InvestorsCancer Genetics
& 1 more
- Employee Count28
- Acquired by
Associated legal entities of BioServe Biotechnologies
BioServe Biotechnologies operates through Bioserve Biotechnologies (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Bioserve Biotechnologies (India) Private Limited CIN U72200TG1994PTC017063 | Active | 21 Feb 1994 | Hyderabad, Telangana | ₹4.2 Cr | 28 | 5 | View details |
Investors in BioServe Biotechnologies
BioServe Biotechnologies has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Cancer Genetics and ReproCELL.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Leading global supplier of iPS-derived cells, stem cell reagents, human biofluids, and 3D cell culture. | 2003 | reprocell.com | Osaka, Japan | |
Cancer diagnostic solutions are developed for personalized genetic treatments. | 1999 | cancergenetics.com | Rutherford, United States |
Investor details for BioServe Biotechnologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Bioserve Biotechnologies (India) Private Limited (BioServe Biotechnologies)
Bioserve Biotechnologies (India) Private Limited is the primary company behind BioServe Biotechnologies. The board of Bioserve Biotechnologies (India) Private Limited currently have 4 directors; the longest-serving is Venkateswarlu Prathipati, appointed in 2017. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkateswarlu Prathipati DIN 07746951 | Director | 23 Feb 2017 | 9 yrs 7 mo | Bioserve Biotechnologies (India) Private Limited |
| Chikafumi Yokoyama DIN 08892826 | Director | 07 Oct 2020 | 6 yrs | Bioserve Biotechnologies (India) Private Limited |
| Daisuke Usui DIN 03610185 | Director | 16 Dec 2020 | 5 yrs 10 mo | Bioserve Biotechnologies (India) Private Limited |
| Bhawna Dubey DIN 10996894 | Director | 01 Apr 2025 | 1 yr 6 mo | Bioserve Biotechnologies (India) Private Limited |
Financials of BioServe Biotechnologies
Figures of Bioserve Biotechnologies (India) Private Limited, the primary company behind BioServe Biotechnologies, for FY 2025. Revenue was ₹4.20 Cr (+32% year on year). Net loss was -₹2.24 Cr (-53% margin). EBITDA was -₹79.7 Lakh (-19% margin). Revenue has grown at a compounded annual rate of -5% over three years and +2% over five years.
- ₹4.20 CrRevenue · FY 2025 · +32% YoY
- -₹2.24 CrNet loss · -53% margin
- -₹79.7 LakhEBITDA · -19% margin
- ₹12.21 CrPaid-up capital
- 28Employees (provident fund records)
- -5%Revenue CAGR, 3 years
- +2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Bioserve Biotechnologies (India) Private Limited are on its company page.
Detailed financial statements for BioServe Biotechnologies
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of BioServe Biotechnologies
3 dated milestones of BioServe Biotechnologies across 16 years, from founding to its latest funding, stage changes and deals.
- Founded BioServe Biotechnologies is founded.
- Exit Acquired by Cancer Genetics.
- Exit Acquired by ReproCELL.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioServe Biotechnologies
BioServe Biotechnologies was founded in 2002.
BioServe Biotechnologies is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
BioServe Biotechnologies has 28 employees.
The primary company behind BioServe Biotechnologies, Bioserve Biotechnologies (India) Private Limited, reported revenue of ₹4.20 Cr for FY 2025, up 32% year on year.
BioServe Biotechnologies was founded in 2002 in Hyderabad, India, within the biotechnology sector. DNA synthesis, sequencing, extraction, and biomarker discovery services are offered to support research and diagnostics. Therapeutics targeting Rett syndrome, Parkinsons disease, glioblastoma, CDKL5 deficiency disorder, and related conditions are developed. Additional services include food pathogen testing and detection of genetically modified organisms in finished products. Molecular biology kits for research purposes are manufactured and supplied.
BioServe Biotechnologies has 2 investors. Key investors include Cancer Genetics, and ReproCELL.
BioServe Biotechnologies operates through Bioserve Biotechnologies (India) Private Limited.
Yes. BioServe Biotechnologies was acquired by ReproCELL in April 2018.
The legal entities of BioServe Biotechnologies currently have 5 directors, including Venkateswarlu Prathipati, Chikafumi Yokoyama, Daisuke Usui and others.